New target: Researchers identify pancreatic cancer resistance mechanism

Pancreatic cancer tumors addicted to mutant Kras signaling for their growth and progression have a ready-made substitute to tap if they're ever forced to go cold-turkey on the mutant oncogene, scientists at The University of Texas MD Anderson Cancer Center report in the journal Cell.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news